Last reviewed · How we verify
Cholinesterase Inhibitors Toxicity
Approved treatments
- (-)-Atropine · University of Kansas Medical Center
- Pralidoxime Chloride (Autoinjector) · Baxter
Pralidoxime Chloride works by reactivating the enzyme acetylcholinesterase, which is inhibited by organophosphate poisoning.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cholinesterase Inhibitors Toxicity patent landscape — cliff calendar, originator estates, attackable patents
- Cholinesterase Inhibitors Toxicity treatment landscape brief
- Cholinesterase Inhibitors Toxicity treatment updates RSS
Frequently asked questions about Cholinesterase Inhibitors Toxicity
What drugs treat Cholinesterase Inhibitors Toxicity?
Tracked treatments include (-)-Atropine, Pralidoxime Chloride (Autoinjector).
What is the treatment for Cholinesterase Inhibitors Toxicity?
Standard treatment for Cholinesterase Inhibitors Toxicity includes (-)-Atropine, Pralidoxime Chloride (Autoinjector). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cholinesterase Inhibitors Toxicity patent cliff · Cholinesterase Inhibitors Toxicity CI report
- Treatment: (-)-Atropine · University of Kansas Medical Center
- Treatment: Pralidoxime Chloride (Autoinjector) · Baxter
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing